Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation

Filippo M. Santorelli, Suk Chun Mak, Marta E. Vazquez-Memije, Sara Shanske, Pamela Kranz-Eble, Karen D. Jain, Daniel L. Bluestone, Darryl C. De Vivo, Salvatore DiMauro

Research output: Contribution to journalArticle

Abstract

The mitochondrial DNA (mtDNA) point mutation T8993G has been associated with maternally inherited Leigh syndrome (MILS) when very abundant (>95%). MILS patients are usually severely affected and die in early infancy. In 1993, a novel T8993C point mutation was described in a juvenile form of Leigh syndrome (LS) characterized by a less aggressive clinical course. We describe four unrelated T8993C patients who had diverse, relatively mild, clinical manifestations. Polymerase chain reaction-restriction fragment length polymphorphism analysis showed that the heteroplasmic T8993C point mutation was very abundant in several tissues from all four patients (94.2 ± 1.5%) but was less copious in blood from 20 maternal relatives. ATP production in mitochondria isolated from skin fibroblasts in three patients was normal, whereas in one patient it was decreased to 20-35% of controls. These findings suggest that the T8993C mutation is less severe than the more common T8993G mutation.

Original languageEnglish
Pages (from-to)914-917
Number of pages4
JournalPediatric Research
Volume39
Issue number5
Publication statusPublished - May 1996

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Santorelli, F. M., Mak, S. C., Vazquez-Memije, M. E., Shanske, S., Kranz-Eble, P., Jain, K. D., Bluestone, D. L., De Vivo, D. C., & DiMauro, S. (1996). Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatric Research, 39(5), 914-917.